Randomized trials on prostate cancer screening are limited by logistical and temporal issues. Modeling can be useful to estimate the results for alternative scenarios not examined in the studies and to explain sources of variation between trials.
- Stacy Loeb
- Sigrid Carlsson
- R. Scott Braithwaite